Related Experiment Video
Updated: Dec 22, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Midazolam Intoxication in a Premature Neonate
Mio Endo1, Ryohei Hirano2, Hiromi Shibasaki2
1Department of Pediatrics, Showa University School of Medicine, Tokyo, Japan.
A neonate experienced adverse cardiorespiratory events from midazolam due to impaired CYP3A activity. Genetic analysis revealed mutations in CYP3A4/5, indicating reduced drug metabolism and potential for toxicity in infants.
Area of Science:
- Pharmacogenomics
- Neonatal Medicine
- Drug Metabolism
Background:
- Midazolam is a common sedative for neonates with respiratory disorders.
- Adverse cardiorespiratory events can occur with midazolam infusion.
- Cytochrome P450 (CYP) enzymes, particularly CYP3A4 and CYP3A5, are crucial for midazolam metabolism.
More Related Videos
15:27Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
Published on: July 13, 2014
08:23Adaptation of Microelectrode Array Technology for the Study of Anesthesia-induced Neurotoxicity in the Intact Piglet Brain
Published on: May 12, 2018
Related Concept Videos
Parenteral Anesthetics: Overview
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Drug Dosing: Infants and Children
CNS Depressants: Barbiturates and Benzodiazepines
Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...